A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer

This study has suspended participant recruitment.
Sponsor:
Information provided by (Responsible Party):
Otsuka Novel Products GmbH
ClinicalTrials.gov Identifier:
NCT02042885
First received: January 17, 2014
Last updated: May 4, 2015
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)